FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular, to gynecology, and is intended for treating papilloma virus induced (HPV) I-II degree cervical intraepithelial neoplasias (CIN) in patients of reproductive age. The patients are examined, three indicators are identified: age of the patient, the viral load of HPV Ig per 10*5 copies before treatment, Category_tBS_code, and the effectiveness of the treatment (y) is evaluated by the formula. With a value of y = -1 to 0 points, the absence of effect from the conducted treatment is predicted, and with values of y = 1 point and above, a favourable outcome of the conducted treatment is predicted.
EFFECT: method allows for an increase in the effectiveness of treatment due to the possibility of predicting the development of progression of cervical intraepithelial neoplasias, personalisation of the treatment of patients in different age groups, and also minimises the risk of development of cervical cancer.
1 cl, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
PREDICTION METHOD OF HPV-ASSOCIATED CERVICAL INTRAEPITHELIAL NEOPLASIA DEVELOPMENT | 2016 |
|
RU2621294C1 |
METHOD FOR PREDICTING THE RISK OF PROGRESSION OF RECURRENT CERVICAL INTRAEPITHELIAL NEOPLASIAS OF LOW DEGREE OF ONCOGENIC RISK ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION | 2020 |
|
RU2748719C1 |
METHOD FOR PREVENTION OF HPV-ASSOCIATED RECURRENCES OF CIN II-III AND CC 1A1 ST | 2020 |
|
RU2737051C2 |
METHOD FOR ASSESSING DEGREE OF MALIGNANCY OF INTRAEPITHELIAL INVOLVEMENT OF SQUAMOUS EPITHELIUM OF UTERUS | 2023 |
|
RU2818148C1 |
METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
Authors
Dates
2022-06-09—Published
2021-04-21—Filed